ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
المؤلف الرئيسي: | R.T. Saygitov |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
"Paediatrician" Publishers LLC
2008-08-01
|
سلاسل: | Вопросы современной педиатрии |
الوصول للمادة أونلاين: | https://vsp.spr-journal.ru/jour/article/view/1441 |
مواد مشابهة
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
حسب: R.T. Saygitov
منشور في: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
حسب: Cardile S, وآخرون
منشور في: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
حسب: Yu. V. Yevsyutina
منشور في: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
حسب: Gold Benjamin D, وآخرون
منشور في: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
حسب: Roy C Orlando, وآخرون
منشور في: (2010-09-01)